Indivior Pharmaceuticals (INDV) Interest & Investment Income (2024 - 2026)

Indivior Pharmaceuticals has reported Interest & Investment Income for 3 years, with the latest figure at $3.0 million in Q2 2026.

• On a quarterly basis, Interest & Investment Income fell 50.0% year-over-year to $3.0 million in Q2 2026; TTM through Jun 2026 was $18.0 million, a 10.0% decrease from a year earlier, with the FY2025 full-year figure at $22.0 million, down 4.35% from the prior year.
• Interest & Investment Income was $3.0 million for Q2 2026 at Indivior Pharmaceuticals, roughly flat from $3.0 million in the prior quarter.
• The five-year high for Interest & Investment Income was $7.0 million in Q1 2024, with the low at $3.0 million in Q1 2026.
• Average Interest & Investment Income over 3 years is $5.1 million, with a median of $5.5 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Interest & Investment Income climbed 20.0% in 2025, then plunged 50.0% in 2026.
• Over 3 years, Interest & Investment Income stood at $5.0 million in 2024, then advanced by 20.0% to $6.0 million in 2025, then slumped by 50.0% to $3.0 million in 2026.
• The last three Interest & Investment Income figures came in at $3.0 million (Q2 2026), $3.0 million (Q1 2026), and $6.0 million (Q4 2025), per Business Quant data.